about
Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation.Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.Using physiologic end points to assess innovations in mechanical ventilation.Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.Inhalation therapy during mechanical ventilation.Future directions in aerosol therapy.Sleep disorders in pregnancy.Basic techniques for aerosol delivery during mechanical ventilation.New frontiers in aerosol delivery during mechanical ventilation.Perioperative treatment of patients with obstructive sleep apnea.Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.Care of the chronic tracheostomy.Gross and subgross anatomy of bronchial circulation in sheep.Inhalation therapy in invasive and noninvasive mechanical ventilation.Inhaled insulin: extending the horizons of inhalation therapy.How best to deliver aerosol medications to mechanically ventilated patients.Aerosol drug delivery: developments in device design and clinical use.What the pulmonary specialist should know about the new inhalation therapies.Respiratory care year in review 2010: part 1. asthma, COPD, pulmonary function testing, ventilator-associated pneumonia.Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.Aerosol therapy in patients receiving noninvasive positive pressure ventilation.The role of nebulized therapy in the management of COPD: evidence and recommendations.Inhalation therapy in patients receiving mechanical ventilation: an update.Inhaled Drug Therapy 2016: The Year in Review.Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.Flexible fiberoptic bronchoscopy in clinical practice--a review of 100 procedures.Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients.Perceptions and attitude towards tobacco smoking among doctors in Chandigarh.Enzyme levels in bronchoalveolar lavage fluid and serum of active pulmonary tuberculosis patients.A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis.Chronic granulocytic leukaemia in a haemophiliac.Laboratory evaluation of metered-dose inhalers with models that simulate interaction with the patient.Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats.Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.How Should Aerosols Be Delivered During Invasive Mechanical Ventilation?Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.COPD in Primary Care: Key Considerations for Optimized Management: Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease.Maximizing aerosol delivery during mechanical ventilation: go with the flow and go slow.
P50
Q32032913-21827CBB-C62B-47FF-A076-DECC7C55EEB4Q33210959-06A4DB42-7D96-4133-BAB2-0BE68747B173Q33567474-FE5EC96C-3677-40E2-A22B-2EFC68B70426Q33968284-9D76BA89-38EC-4D54-B900-F5FA98E70654Q34343462-BA6A10E1-387E-4A5F-8707-82052B722942Q34343479-91D2C0D6-F36F-4501-8925-6C55C40CD9D6Q35554381-0654DF81-6B65-4371-9B32-F2F001FFB078Q35785310-5F210A10-D024-408C-923A-2EFD57818776Q35785337-4D153C22-7B03-407D-9B57-66237118448EQ35930585-AEB130DD-C667-4368-912D-278C2E200CD2Q36268519-B87BAF60-42F8-4857-AFED-D5302E249307Q36577978-83DF9269-5B5F-4A15-B178-49D163F94F4EQ36608386-3DBD28FA-7D9B-4EA0-AED7-2B78F36C275FQ36696566-666A9DD6-27E1-4112-98EC-F7FA54D95017Q36862068-D14C245C-08D3-4288-839A-825DE549631AQ37148902-CF751E5A-841F-4AD8-81F8-84C7527AD30EQ37805216-5626242C-B2B3-4EFD-8314-830220E1C783Q37839525-12ED915A-4E0A-4232-ACE7-A100365C088FQ37865602-31176C16-ECF4-4B29-90D7-576A3006CCB7Q37915360-0C46E8C7-024F-4317-A642-660D0AB7506CQ37970700-6391E874-E29C-409B-8940-3181E6F177A4Q37980189-F286E9AE-2E2D-467F-85D2-0F0453C5C6F5Q38031576-B7597D20-D484-408A-B296-5E7E66226C08Q39339127-63A3CC9B-EDA2-44E8-B6D2-C7929F0061F2Q39644607-B2F0766D-0B7F-4246-90DB-08BBE1009979Q39806741-017A9ACC-AC36-4398-8144-7B2459B0C859Q41054588-F789AC11-A90C-4DF8-966F-08CC32B7A7E6Q44222416-442B1E64-4D88-4E6D-B894-EC0F980787C8Q44369324-8BBDA314-9129-4178-922B-2C213AB5EC12Q45224944-DF45E21D-619B-45FB-8BA4-C154FF144C8BQ45888835-A74C2BA3-4A71-4DDF-BB02-2100D7E3DFE2Q46053760-61ED8F6D-4550-4F24-8A7B-AAA1D63A4734Q46064803-6D27431C-B257-4A26-81B7-AE9C3E61A8B6Q46839239-DC375DE4-3626-4076-998F-C98297072C77Q47222392-0F6AB047-110F-4F9F-A2EC-E1032A1E22F5Q47730320-8579D6EB-11F2-4B77-85E7-22A4F226AFBAQ47782286-2A821059-604B-4F60-8CAD-0E4B7DCEE276Q47789987-74C7C7F2-F85D-45DF-B21B-FF40C96FA1C8Q50006680-A442A266-73F3-400E-B3DF-3F7FD41C0281Q51658785-17788B68-E4A4-4E4F-8713-A8B9FEF7C73A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rajiv Dhand
@ast
Rajiv Dhand
@en
Rajiv Dhand
@es
Rajiv Dhand
@nl
type
label
Rajiv Dhand
@ast
Rajiv Dhand
@en
Rajiv Dhand
@es
Rajiv Dhand
@nl
prefLabel
Rajiv Dhand
@ast
Rajiv Dhand
@en
Rajiv Dhand
@es
Rajiv Dhand
@nl
P106
P31
P496
0000-0002-3621-2422